Lonza Licenses PC Ingredient

June 21, 2004

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal


Lonza Licenses PC Ingredient

BASEL, SwitzerlandLonza Inc. (www.lonza.com) signed a licensing agreement with Calgary, Alberta-based SemBioSys Genetics Inc. giving Lonza global rights to SemBioSys DermaSphere ingredient system for use in personal care markets. Lonza will develop, produce and market non-transgenic oilbody-based ingredients to be used in cosmetic and skin care products. DermaSphere is a natural oil-in-water emulsion in which oil is surrounded by phospholipids and oleosin protein.

SemBioSys (www.sembiosys.com) has patents on the product in the United States, Canada and other countries.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like